Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort

Detalles Bibliográficos
Autores principales: van Lunzen, J, Gorriahn, D, Wünsche, T, Dupke, S, Gute, P, Schewe, CK, Ranneberg, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113029/
http://dx.doi.org/10.1186/1758-2652-13-S4-P28
_version_ 1782205871901638656
author van Lunzen, J
Gorriahn, D
Wünsche, T
Dupke, S
Gute, P
Schewe, CK
Ranneberg, B
author_facet van Lunzen, J
Gorriahn, D
Wünsche, T
Dupke, S
Gute, P
Schewe, CK
Ranneberg, B
author_sort van Lunzen, J
collection PubMed
description
format Online
Article
Text
id pubmed-3113029
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130292011-06-13 Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort van Lunzen, J Gorriahn, D Wünsche, T Dupke, S Gute, P Schewe, CK Ranneberg, B J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113029/ http://dx.doi.org/10.1186/1758-2652-13-S4-P28 Text en Copyright ©2010 van Lunzen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
van Lunzen, J
Gorriahn, D
Wünsche, T
Dupke, S
Gute, P
Schewe, CK
Ranneberg, B
Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort
title Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort
title_full Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort
title_fullStr Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort
title_full_unstemmed Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort
title_short Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort
title_sort efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a german outpatient cohort
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113029/
http://dx.doi.org/10.1186/1758-2652-13-S4-P28
work_keys_str_mv AT vanlunzenj efficacyandtolerabilityofdarunavirr600100mgbidintreatmentexperiencedpatients48weekdatafromagermanoutpatientcohort
AT gorriahnd efficacyandtolerabilityofdarunavirr600100mgbidintreatmentexperiencedpatients48weekdatafromagermanoutpatientcohort
AT wunschet efficacyandtolerabilityofdarunavirr600100mgbidintreatmentexperiencedpatients48weekdatafromagermanoutpatientcohort
AT dupkes efficacyandtolerabilityofdarunavirr600100mgbidintreatmentexperiencedpatients48weekdatafromagermanoutpatientcohort
AT gutep efficacyandtolerabilityofdarunavirr600100mgbidintreatmentexperiencedpatients48weekdatafromagermanoutpatientcohort
AT scheweck efficacyandtolerabilityofdarunavirr600100mgbidintreatmentexperiencedpatients48weekdatafromagermanoutpatientcohort
AT rannebergb efficacyandtolerabilityofdarunavirr600100mgbidintreatmentexperiencedpatients48weekdatafromagermanoutpatientcohort

Ejemplares similares